Nivolumab,Ipilimumab
BMS
['rectal', 'agent', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm']
the minimum duration/dose of io (single agent or combination) for achieving a complete response need to be figured out for neoadj use for early stage msi-h colon &amp; rectal cancer. #esmo22 #crcsm 
Pt Adv, NCI Rectal Anal TF
Mom, lifelong learner
Wants to bring patient voice to research, clinical trials & more!
Check out @CRCTrialsChat
1st love: Virology